Income Statement (TTM)
Valiant Laboratories Limited Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.
All numbers are times 1,000,000 except per share units.
|
2022 03-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
2024 12-31 |
2025 03-31 |
2025 06-30 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3,124 | 3,339 | 2,994 | 2,730 | 2,427 | 1,821 | 1,495 | 1,115 | 1,062 | 1,334 | 1,613 |
| Change (%) | 6.90 | -10.34 | -8.81 | -11.08 | -25.00 | -17.86 | -25.46 | -4.74 | 25.61 | 20.95 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 2,530 | 2,789 | 2,482 | 2,273 | 2,130 | 1,705 | 1,472 | 1,130 | 1,005 | 1,170 | 1,373 |
| Change (%) | 10.27 | -11.02 | -8.42 | -6.28 | -19.97 | -13.67 | -23.25 | -10.99 | 16.36 | 17.38 | |
| % of Revenue | 80.98 | 83.53 | 82.90 | 83.26 | 87.76 | 93.64 | 98.42 | 101.33 | 94.69 | 87.71 | 85.12 |
| Gross Operating Profit | 594 | 550 | 512 | 457 | 297 | 116 | 24 | -15 | 56 | 164 | 240 |
| Change (%) | -7.45 | -6.88 | -10.72 | -34.99 | -61.04 | -79.63 | -163.08 | -479.18 | 190.64 | 46.43 | |
| % of Revenue | 19.02 | 16.47 | 17.10 | 16.74 | 12.24 | 6.36 | 1.58 | -1.33 | 5.31 | 12.29 | 14.88 |
| SG&A | 33 | 46 | 45 | 47 | 48 | 43 | 45 | 46 | 45 | 44 | 46 |
| Change (%) | 37.93 | -2.10 | 3.53 | 2.03 | -9.59 | 3.57 | 3.34 | -2.07 | -2.92 | 5.40 | |
| % of Revenue | 1.07 | 1.38 | 1.51 | 1.71 | 1.97 | 2.37 | 2.99 | 4.14 | 4.26 | 3.29 | 2.87 |
| R&D | |||||||||||
| Change (%) | |||||||||||
| % of Revenue | |||||||||||
| OpEx | 2,689 | 3,004 | 2,698 | 2,525 | 2,390 | 1,924 | 1,662 | 1,335 | 1,213 | 1,402 | 1,633 |
| Change (%) | 11.72 | -10.19 | -6.40 | -5.35 | -19.48 | -13.64 | -19.67 | -9.13 | 15.53 | 16.52 | |
| % of Revenue | 86.08 | 89.96 | 90.10 | 92.49 | 98.46 | 105.70 | 111.13 | 119.77 | 114.25 | 105.08 | 101.23 |
| Operating Income | 435 | 335 | 296 | 205 | 37 | -104 | -166 | -220 | -151 | -68 | -20 |
| Change (%) | -22.91 | -11.64 | -30.83 | -81.71 | -376.73 | 60.51 | 32.33 | -31.33 | -55.24 | -70.73 | |
| % of Revenue | 13.92 | 10.04 | 9.90 | 7.51 | 1.54 | -5.70 | -11.13 | -19.77 | -14.25 | -5.08 | -1.23 |
| Interest Expense | -0 | -3 | -2 | -1 | -1 | -1 | -1 | -1 | -1 | -2 | -2 |
| Change (%) | 598.90 | -29.15 | -41.64 | -20.59 | -6.72 | 43.24 | -11.77 | 44.09 | 22.69 | 12.73 | |
| % of Revenue | -0.01 | -0.08 | -0.06 | -0.04 | -0.03 | -0.04 | -0.07 | -0.09 | -0.13 | -0.13 | -0.12 |
| Net Income | 341 | 290 | 276 | 227 | 111 | 3 | -45 | -100 | -41 | -22 | 1 |
| Change (%) | -14.89 | -4.85 | -17.69 | -50.94 | -97.13 | -1,494.96 | 124.13 | -58.52 | -46.89 | -105.86 | |
| % of Revenue | 10.91 | 8.68 | 9.22 | 8.32 | 4.59 | 0.18 | -2.98 | -8.96 | -3.90 | -1.65 | 0.08 |
Source: Capital IQ
